Skip to main content
OpenTrials
Completed

NCT Number: NCT01343472

Evaluation of the Washington Intensive Supervision Program

This study entails an evaluation of the Washington Intensive Supervision Program (WISP). The purpose of the evaluation is to test whether subjects assigned to WISP perform better than those assigned to parole-as-usual (PAU).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Behavior Chemically-Induced Disorders Drug Misuse Drug Users Mental Disorders Substance-Related Disorders

Age range

18 year and older

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Seattle Community Justice Center

Seattle, Washington, United States

About this study

This study entails an evaluation of the Washington Intensive Supervision Program (WISP). WISP is a program targeting high-risk parolees in Seattle, and is modeled after the HOPE program in Hawaii. The purpose of the evaluation is to test whether subjects assigned to WISP perform better than those assigned to parole-as-usual (PAU) on a number of outcomes, including drug use, missed appointments, recidivism, prison and jail stays, and parole revocations. WISP uses regular random drug testing and close community supervision, paired with swift and certain, but modest sanctions for every detected violation.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Inmates released by DOC to community corrections supervision
  • Supervised out of the Seattle CJC (Community Justice Center) to include field offices and offenders from the downtown "Metro" unit, Southeast Seattle unit, Northgate (north Seattle) and West Seattle.
  • Have a parole supervision discharge date at least one year from the date of release from entry into WISP

Exclusion criteria

  • Level III Sex Offenders
  • Existing assignment to supervision that precludes WISP. These include: Drug Offender Sentencing Alternative (DOSA)and Special Sex Offender Sentencing Alternative (SSOSA).
  • Dangerously Mentally Ill (DMIO)

Treatment and study plan

WISP supervision

Behavioral

WISP entails a warning session (Orientation Hearing) where the rules of parole are laid out and parolees are told that any violation of stated parole conditions will be sanctioned with a brief jail term (typically a few days in jail). WISP includes regular random drug testing.

Other names: HOPE supervision

Parole-as-usual

Behavioral

Parolees are supervised under standard parole supervision practice in Washington State.

Other names: PAU

Primary outcomes

  1. Revocation rate

    Time frame: 12 months

    Percentage of subjects in each condition who are revoked from parole and returned to prison

Secondary outcomes

  1. % positive drug tests

    Time frame: 12 months

    Percentage of random and scheduled drug tests that test positive for illicit drugs

  2. Days incarcerated

    Time frame: 12 months

    Total number of days incarcerated in jail or prison

  3. % Missed appointments

    Time frame: 12 months

    Percentage of parole appointments that are missed.

  4. New arrests

    Time frame: 12 months

    Number of new arrests.

  5. Assessed risk

    Time frame: 12 months

    Parolee risk assessment (high, medium, low)

Sponsors and collaborators

Lead sponsor

Pepperdine University

Other

Registry information

Important dates

Study start
2011
Primary completion
2012
Study completion
2012
First posted
Apr 28, 2011
Registry last updated
Apr 10, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.